ClearAngel Invests $10,000 in Canine Performance Brand The Old Wolf Supplements

Share Article

As company enters its fourth year of business, ClearAngel primes The Old Wolf Supplements to have their most successful season to date

News Image
“For The Old Wolf Supplements, this ClearAngel investment will help bring their innovative approach to canine wellness to exponentially more dogs around the world," said Andrew D’Souza, CEO and co-founder, Clearco.

Clearco, the world’s largest e-commerce investor revolutionizing the way founders grow their businesses, today announced that its industry-leading ClearAngel program is funding The Old Wolf Supplements, a performance supplement company for dogs with a mission to encourage dog owners to be more active with their faithful companions. ClearAngel gives early-stage companies access to revenue share capital, data-driven advice, and an extensive network of apps, agencies, and investors powered by Clearco.

Founded in 2018, The Old Wolf Supplements is one of the first companies in the world of dog sport to offer a range of performance supplements in order to improve muscular development, recuperation after effort and especially dog health. Trained as an active Canicross runner, founder Shawn Beaulieu is an expert on the types of high-energy food and supplements dogs need to maintain their liveliness and energy for years. He shares this expertise not only in supplements but also by using The Old Wolf Supplements as a platform to provide tailored advice for dog owners to achieve their wanted goals.

The Old Wolf Supplements have reached great success in their sales but are interested in scaling their business to the next level. ClearAngel’s investment will help the company to recruit an impressive advertising team to reach their goal of $20,000 in sales per month. ClearAngel is among just a few equity-free, flexible capital options for early-stage founders who lack the network to raise an angel round or join exclusive accelerators. Since its February 2021 launch, the program has already funded over 350 companies.

“We’re excited to fund The Old Wolf Supplements in its mission to support the health and growth of dogs worldwide,” said Andrew D’Souza, CEO and co-founder, Clearco. “For The Old Wolf Supplements, this ClearAngel investment will help bring their innovative approach to canine wellness to exponentially more dogs around the world.”

In addition to $10,000 of flexible capital, The Old Wolf Supplements will also get access to a network of more than 500 investors, growth teams, agencies, apps, lawyers, and buyers; and data-driven advice designed to help scale and hit new revenue milestones.

“Having access to ClearAngel’s impressive network has already kickstarted the company into thinking about the most strategic ways to grow,” said Shawn Beaulieu, Founder, The Old Wolf Supplements. “We are dedicated to encouraging dog owners around the world to be more active with their canine companions and we’re excited to bring our products to a whole new market​​.”

To learn more about The Old Wolf Supplements and experience their products for yourself, visit

ClearAngel is currently onboarding E-commerce and product companies. The program has limited spots available for SaaS, Apps, marketplace and stealth companies. To learn more about applying, visit

About Clearco:
Co-founded as Clearbanc in 2015 by Michele Romanow from Canada’s Shark Tank (Dragons’ Den), Andrew D’Souza, Ivan Gritsiniak, Charlie Feng, and Tanay Delima, Clearco offers the most founder-friendly capital solutions for e-commerce, mobile apps, and SaaS founders as well as a full suite of products and access to a powerful global network, insights and data, and recommendations. Clearco has invested over $2 Billion in over 4,500 companies to date, including Leesa Sleep, fashion-rental service Le Tote, home goods company Public Goods, shirtmaker UNTUCKit, online speech therapy practice Expressable, and digital real estate marketplace SetSchedule. For more information visit and @getClearco.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Krista Tietjen
Email >
Visit website